Elicio Therapeutics logo

Elicio Therapeutics

ID: 5870929

Elicio Therapeutics is an HPV-induced cancer treatments founded in 2011 by Satish Jindal.

6

Funding Rounds

$224.4m

Money raised

Overview

Elicio Therapeutics is an HPV-induced cancer treatments founded in 2011 by Satish Jindal.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Elicio Therapeutics has raised a total of $153m in funding over 6 rounds.

Key Insights:

  • Elicio Therapeutics Funding Round, May 2022: $50m
  • Elicio Therapeutics Series B round, February 2021: $73m
  • Elicio Therapeutics , March 2019: $30m
  • Elicio Therapeutics, Inc. funding round, July 2020: $30m
  • Elicio Therapeutics funding round, October 2019: $33m
  • Elicio Therapeutics, Inc. funding round, March 2020: $8.41m

Industries

Elicio Therapeutics is active in the following industries: